Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human interferon alpha-1b for EV71-associated hand, foot, and mouth disease in children
ChiCTR-TRC-14005153Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human interferon alpha-1b in enterovirus 71 infection (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Time to temperature normalization, Time to rash disappearance and 2 more. Started Aug 2014; status: recruiting.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
enterovirus 71 infection
Beyond the preview
Go deeper on ChiCTR-TRC-14005153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005153.